HUGO is a clinical research technological platform, based on Big Data and artificial intelligence technologies, aimed at collecting real-life health data from Multiple Sclerosis patients, through their mobile devices, and revaluing the information to improve knowledge. and treatments for this disease.
This tool is designed for collaborative research, where patients will use an App to manage their disease, and at the same time, share their health data and lifestyle habits with thousands of patients like them, centralizing all this data in the same database. data that will allow us to investigate and improve knowledge of the treatments for patients with Multiple Sclerosis. The platform will provide relevant and complementary scientific evidence to traditional clinical trials to increase R&D productivity and improve current treatments for the pharmaceutical industry and improve quality of life and disease management for patients.